Homebiotech

biotech

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026

biotech

Positive topline results from phase 2 recurrent ovarian cancer trial

Jim Cornall - May 26, 2026

biotech

Rare oral cancer has distinct genetic profile

Jim Cornall - May 26, 2026

biotech

New tool decodes structures and motifs of RNA

Jim Cornall - May 26, 2026

AI

Base to Base biotech podcast 39: Gene therapy for eye problems, GAIA, and separation science

Jim Cornall - December 12, 2025

biotech

Endpoints not met, but data provides insights to Alzheimer’s pathobiology

Jim Cornall - December 11, 2025

biotech

CRS programme to feature Poolbeg Pharma trial

Jim Cornall - December 11, 2025

AI

ChemLex raises $45m and launches lab for drug discovery in Singapore

Jim Cornall - December 11, 2025

biotech

Potent and selective antitumour activity in acute myeloid leukaemia study

Jim Cornall - December 10, 2025

biotech

Positive results from male and female infertility monoclonal antibody trial

Jim Cornall - December 10, 2025

biotech

Positive results from ALS study

Jim Cornall - December 10, 2025

biotech

EspeRare receives Gates Foundation grant to advance preeclampsia novel therapy

Jim Cornall - December 9, 2025

1...343536...78 Page 35 of 78

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Restoring the “longevity protein”

Jim Cornall - May 27, 2026 0

Avaí Bio, Inc., an emerging biotechnology company developing cell-based therapies for diabetes, age-related disorders, and anti-aging, has announced - together with its joint venture...

Positive topline results from phase 2 recurrent ovarian cancer trial

biotech Jim Cornall - May 26, 2026 0

Rare oral cancer has distinct genetic profile

biotech Jim Cornall - May 26, 2026 0

New tool decodes structures and motifs of RNA

biotech Jim Cornall - May 26, 2026 0

Elite immune cells lead fight against multiple myeloma

biotech Jim Cornall - May 25, 2026 0